{
     "PMID": "26155834",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160810",
     "LR": "20170220",
     "IS": "2045-2322 (Electronic) 2045-2322 (Linking)",
     "VI": "5",
     "DP": "2015 Jul 9",
     "TI": "Involvement of PrP(C) in kainate-induced excitotoxicity in several mouse strains.",
     "PG": "11971",
     "LID": "10.1038/srep11971 [doi]",
     "AB": "The cellular prion protein (PrP(C)) has been associated with a plethora of cellular functions ranging from cell cycle to neuroprotection. Mice lacking PrP(C) show an increased susceptibility to epileptic seizures; the protein, then, is neuroprotective. However, lack of experimental reproducibility has led to considering the possibility that other factors besides PrP(C) deletion, such as the genetic background of mice or the presence of so-called \"Prnp flanking genes\", might contribute to the reported susceptibility. Here, we performed a comparative analysis of seizure-susceptibility using characterized Prnp(+/+) and Prnp(0/0) mice of B6129, B6.129, 129/Ola or FVB/N genetic backgrounds. Our study indicates that PrP(C) plays a role in neuroprotection in KA-treated cells and mice. For this function, PrP(C) should contain the aa32-93 region and needs to be linked to the membrane. In addition, some unidentified \"Prnp-flanking genes\" play a role parallel to PrP(C) in the KA-mediated responses in B6129 and B6.129 Prnp(0/0) mice.",
     "FAU": [
          "Carulla, Patricia",
          "Llorens, Franc",
          "Matamoros-Angles, Andreu",
          "Aguilar-Calvo, Patricia",
          "Espinosa, Juan Carlos",
          "Gavin, Rosalina",
          "Ferrer, Isidre",
          "Legname, Giuseppe",
          "Torres, Juan Maria",
          "del Rio, Jose A"
     ],
     "AU": [
          "Carulla P",
          "Llorens F",
          "Matamoros-Angles A",
          "Aguilar-Calvo P",
          "Espinosa JC",
          "Gavin R",
          "Ferrer I",
          "Legname G",
          "Torres JM",
          "del Rio JA"
     ],
     "AD": "1] Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Cientific de Barcelona, Barcelona, Spain [2] Department of Cell Biology, Universitat de Barcelona, Barcelona, Spain [3] Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. 1] Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Cientific de Barcelona, Barcelona, Spain [2] Department of Cell Biology, Universitat de Barcelona, Barcelona, Spain [3] Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain [4] German Center for Neurodegenerative Diseases (DZNE), Robert-Koch Str. 40, 37075, Gottingen, Germany. 1] Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Cientific de Barcelona, Barcelona, Spain [2] Department of Cell Biology, Universitat de Barcelona, Barcelona, Spain [3] Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. Centro de Investigacion en Sanidad Animal (CISA-INIA), Valdeolmos, Madrid, Spain. Centro de Investigacion en Sanidad Animal (CISA-INIA), Valdeolmos, Madrid, Spain. 1] Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Cientific de Barcelona, Barcelona, Spain [2] Department of Cell Biology, Universitat de Barcelona, Barcelona, Spain [3] Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. 1] Institut de Neuropatologia, IDIBELL-Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain [2] Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy. Centro de Investigacion en Sanidad Animal (CISA-INIA), Valdeolmos, Madrid, Spain. 1] Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Cientific de Barcelona, Barcelona, Spain [2] Department of Cell Biology, Universitat de Barcelona, Barcelona, Spain [3] Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150709",
     "PL": "England",
     "TA": "Sci Rep",
     "JT": "Scientific reports",
     "JID": "101563288",
     "RN": [
          "0 (Biomarkers)",
          "0 (Cytokines)",
          "0 (Inflammation Mediators)",
          "0 (PrPC Proteins)",
          "SIV03811UC (Kainic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Biomarkers",
          "Cell Death",
          "Cell Line",
          "Cytokines/metabolism",
          "Disease Models, Animal",
          "Gene Expression",
          "Genetic Predisposition to Disease",
          "Gliosis/etiology/metabolism/pathology",
          "Hippocampus/metabolism/pathology",
          "Inflammation Mediators/metabolism",
          "Kainic Acid/*toxicity",
          "Mice",
          "Mice, Knockout",
          "PrPC Proteins/*genetics",
          "Seizures/etiology/metabolism/pathology",
          "Transfection"
     ],
     "PMC": "PMC4648388",
     "EDAT": "2015/07/15 06:00",
     "MHDA": "2016/08/11 06:00",
     "CRDT": [
          "2015/07/10 06:00"
     ],
     "PHST": [
          "2015/02/19 00:00 [received]",
          "2015/06/12 00:00 [accepted]",
          "2015/07/10 06:00 [entrez]",
          "2015/07/15 06:00 [pubmed]",
          "2016/08/11 06:00 [medline]"
     ],
     "AID": [
          "srep11971 [pii]",
          "10.1038/srep11971 [doi]"
     ],
     "PST": "epublish",
     "SO": "Sci Rep. 2015 Jul 9;5:11971. doi: 10.1038/srep11971.",
     "term": "hippocampus"
}